Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barohn

Showing results (211-220 of 345) with videos related to

Pageof 35
Sort By:
Muscle & Nerve|April 25, 2022
Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosisSwathy Chandrashekhar, Anai C Hamasaki, Rebecca Clay, et al.
Kansas Journal of Medicine|April 8, 2020
A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of MigraineDipika Aggarwal, Andrew J Heim, Brennen Bittel, et al.
Annals of Neurology|July 1, 1989
Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular geneticsA Lombes, J R Mendell, H Nakase, et al.
Neurology|August 1, 1994
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysisL J Ptáĉek, R Tawil, R C Griggs, et al.
Contemporary Clinical Trials Communications|November 15, 2023
Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPNAlexandra R Brown, Byron J Gajewski, Dinesh Pal Mudaranthakam, et al.
Muscle & Nerve|July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trialMichael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
Neurology|September 25, 1999
Brachial amyotrophic diplegia: a slowly progressive motor neuron disorderJ S Katz, G I Wolfe, P B Andersson, et al.
Muscle & Nerve|January 16, 2009
Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patientsCarlayne E Jackson, Gary Gronseth, Jeffrey Rosenfeld, et al.
The International Journal of Neuroscience|June 16, 2011
Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathyManoj Mittal, Mamatha Pasnoor, Reddiah B Mummaneni, et al.
Arthritis Care & Research|May 17, 2012
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)Lisa G Rider, Victoria P Werth, Adam M Huber, et al.
Pageof 35

Showing results (211-220 of 345) with videos related to

Sort By:
Pageof 35
Muscle & Nerve|April 25, 2022
Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosisSwathy Chandrashekhar, Anai C Hamasaki, Rebecca Clay, et al.
Kansas Journal of Medicine|April 8, 2020
A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of MigraineDipika Aggarwal, Andrew J Heim, Brennen Bittel, et al.
Annals of Neurology|July 1, 1989
Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular geneticsA Lombes, J R Mendell, H Nakase, et al.
Neurology|August 1, 1994
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysisL J Ptáĉek, R Tawil, R C Griggs, et al.
Contemporary Clinical Trials Communications|November 15, 2023
Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPNAlexandra R Brown, Byron J Gajewski, Dinesh Pal Mudaranthakam, et al.
Muscle & Nerve|July 17, 2015
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trialMichael Benatar, Michael P Mcdermott, Donald B Sanders, et al.
Neurology|September 25, 1999
Brachial amyotrophic diplegia: a slowly progressive motor neuron disorderJ S Katz, G I Wolfe, P B Andersson, et al.
Muscle & Nerve|January 16, 2009
Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patientsCarlayne E Jackson, Gary Gronseth, Jeffrey Rosenfeld, et al.
The International Journal of Neuroscience|June 16, 2011
Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathyManoj Mittal, Mamatha Pasnoor, Reddiah B Mummaneni, et al.
Arthritis Care & Research|May 17, 2012
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)Lisa G Rider, Victoria P Werth, Adam M Huber, et al.
Pageof 35